Imperial College London Featured PhD Programmes
King’s College London Featured PhD Programmes
University of Kent Featured PhD Programmes
University of Exeter Featured PhD Programmes
University of Reading Featured PhD Programmes
"pharmacology"×
10 miles

Cancer / Oncology (pharmacology) PhD Projects, Programs & Scholarships

We have 16 Cancer / Oncology (pharmacology) PhD Projects, Programs & Scholarships

  • "pharmacology" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 1 to 16 of 16
  PhD in Chemical Biology -- Neuropeptide Research -- University of Vienna
  Prof M Muttenthaler
Applications accepted all year round

Funding Type

PhD Type

Neuropeptides are key mediators in many biological functions and understanding their interaction with target proteins is fundamental to unravel the underlying mechanism of diseases.
  Neuropeptide Research - PhD Opportunity at a World Class Institution
  Assoc Prof M Muttenthaler, Assoc Prof I Vetter
Applications accepted all year round

Funding Type

PhD Type

We are seeking talented and highly motivated PhD candidates for the following multidisciplinary project. Neuropeptides are key mediators in many biological functions and understanding their interaction with target proteins is fundamental to unravel the underlying mechanism of diseases.
  Targeting ageing: Genes and compounds with pro-longevity, health-preserving effects
  Dr JP de Magalhaes
Applications accepted all year round

Funding Type

PhD Type

Ageing is arguably the major biomedical challenge of the 21st century. In model organisms, the process of ageing can be manipulated by both genetic manipulations and dietary interventions.
  Targeting the Gas6-TAM receptor signalling pathway in cancer
  Dr S Hafizi
Applications accepted all year round

Funding Type

PhD Type

Applications are invited for a self-funded 3 year full-time PhD project, to commence in October 2019 or February 2020. The PhD will be based in the School of Pharmacy and Biomedical Sciences and will be supervised by Dr Sassan Hafizi.
  To develop an allosteric inhibitor of HDAC6 inhibition in cancer
  Dr F Furlong, Dr I Tikhonova
Applications accepted all year round

Funding Type

PhD Type

The HDAC6 protein is upregulated in cancer and associated with increased proliferation and metastasis. Several HDAC6 inhibitors have been developed and are in clinical trials.
  Exploiting the endocannabinoid system in chronic lymphocytic leukaemia
  Dr F Murray, Dr J Hislop, Prof R Pertwee, Prof M A Vickers
Application Deadline: 17 February 2020

Funding Type

PhD Type

Endocannabinoids, such as anandamide and 2-arachidonoyl glycerol, are endogenous cannabinoids produced in mammalian tissues that are anti-proliferative, anti-metastatic and pro-apoptotic in lymphoma and leukaemia.
  Targeting cancer stem cells in acute myeloid leukaemia (AML)
  Prof K Kranc, Prof D O'carroll
Application Deadline: 7 February 2020

Funding Type

PhD Type

Applications are invited for a Clinical Fellowship at the Barts Cancer Institute (Queen Mary University of London) to join a dynamic research group led by Professor Kamil R Kranc.
  Targeting ERK5 to enhance the DNA damage response to radiotherapy and chemotherapy
  Dr K Finegan, Dr C Demonacos
Applications accepted all year round

Funding Type

PhD Type

ERK5 is a signalling protein that enables cells to transduce extracellular signals into responses. It is expressed in all tissues and is up-regulated in tumours.
  Design, synthesis and evaluation of novel polysialyltransferase inhibitors as anti- metastatic agents
  Research Group: Institute of Cancer Therapeutics
  Dr R Falconer, Dr S Shnyder
Applications accepted all year round

Funding Type

PhD Type

Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases (polySTs).
  Design, synthesis and evaluation of protease-activated anti-cancer prodrugs
  Research Group: Institute of Cancer Therapeutics
  Dr R Falconer, Prof P Loadman
Applications accepted all year round

Funding Type

PhD Type

Matrix metalloproteinases (MMPs) are a family of endoproteases that are overexpressed in tumours and play crucial roles in many tumourigenic processes, not least tumour invasion and angiogenesis.
  Polysialyltransferases as a target in metastatic cancer
  Research Group: Institute of Cancer Therapeutics
  Dr R Falconer, Dr S Shnyder
Applications accepted all year round

Funding Type

PhD Type

Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases.
  Vanadium N-Heterocyclic carbenes: Towards new metal-based anti-cancer agents (LORDRU20SCIEC)
  Dr R Lord, Dr J Fielden
Application Deadline: 30 January 2020

Funding Type

PhD Type

Platinum-based therapeutics dominate the clinical drug market for the treatment of cancer. And although these complexes have been crucial in the fight against cancer, they have some major drawbacks associated with their use.
  DMD gene in development and cancer
  Dr M Parker, Prof D Gorecki
Application Deadline: 23 February 2020

Funding Type

PhD Type

Applications are invited for a fully-funded three year PhD to commence in October 2020. The PhD will be based in the Faculty of Science and Health, and will be supervised by Dr Matt Parker and Prof Darek Gorecki.
  Mechanisms of Cancer Stem Cell Survival, Metastasis Formation and Immune Evasion in Cancer
  Dr D Widera
Applications accepted all year round

Funding Type

PhD Type

Recent research suggests that cancer cells within a tumour represent a highly heterogeneous cell population. In particular many tumours contain small percentage of cells that share several characteristics with stem cells.
  Reversing multidrug chemoresistance in head and neck cancer
  Dr M T Teh
Applications accepted all year round

Funding Type

PhD Type

Background. Multidrug resistance renders chemotherapeutic treatment failure in large proportion of head and neck squamous cell carcinoma (HNSCC) patients requiring multimodal therapy involving chemotherapy in conjunction with surgery and/or radiotherapy.
  Carbohydrate analysis for biomedical applications.
  Dr S Allman
Applications accepted all year round

Funding Type

PhD Type

Changes in the patterns of carbohydrates produced by the cell can provide insights into disease states, revealing perturbations and differences in cellular metabolic processes.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2020
All rights reserved.